Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | Proca1 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of PROCA1 mRNA | CTD | PMID:28960355 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of PROCA1 mRNA | CTD | PMID:31614463 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Proca1 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Proca1 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Proca1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PROCA1 mRNA | CTD | PMID:26290441 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Proca1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PROCA1 mRNA | CTD | PMID:33387578 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Proca1 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of PROCA1 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | ISO | Proca1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of PROCA1 mRNA | CTD | PMID:25825206 and PMID:30047161 | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of PROCA1 promoter | CTD | PMID:30157460 | aflatoxin M1 | increases expression | EXP | | 6480464 | Aflatoxin M1 results in increased expression of PROCA1 mRNA | CTD | PMID:30928695 | amitrole | decreases expression | ISO | Proca1 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of PROCA1 mRNA | CTD | PMID:30047161 | atrazine | increases expression | ISO | Proca1 (Rattus norvegicus) | 6480464 | Atrazine results in increased expression of PROCA1 mRNA | CTD | PMID:36841081 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of PROCA1 5' UTR more ... | CTD | PMID:27901495 | benzo[b]fluoranthene | increases expression | ISO | Proca1 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of PROCA1 mRNA | CTD | PMID:26377693 | benzo[e]pyrene | decreases methylation | EXP | | 6480464 | benzo(e)pyrene results in decreased methylation of PROCA1 intron | CTD | PMID:30157460 | bisphenol A | decreases expression | ISO | Proca1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of PROCA1 mRNA | CTD | PMID:25181051 | bisphenol A | increases methylation | ISO | Proca1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of PROCA1 gene | CTD | PMID:28505145 | butanal | decreases expression | EXP | | 6480464 | butyraldehyde results in decreased expression of PROCA1 mRNA | CTD | PMID:26079696 | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PROCA1 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PROCA1 mRNA | CTD | PMID:35301059 | carbon nanotube | decreases expression | ISO | Proca1 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of PROCA1 mRNA | CTD | PMID:25554681 | dibutyl phthalate | decreases expression | ISO | Proca1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of PROCA1 mRNA | CTD | PMID:21266533 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PROCA1 mRNA | CTD | PMID:27188386 | ethylparaben | decreases expression | EXP | | 6480464 | ethyl-p-hydroxybenzoate results in decreased expression of PROCA1 mRNA | CTD | PMID:37690743 | folic acid | decreases expression | ISO | Proca1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of PROCA1 mRNA | CTD | PMID:25629700 | genistein | increases expression | ISO | Proca1 (Mus musculus) | 6480464 | Genistein results in increased expression of PROCA1 mRNA | CTD | PMID:32186404 | gentamycin | increases expression | ISO | Proca1 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of PROCA1 mRNA | CTD | PMID:33387578 | glycidol | decreases expression | ISO | Proca1 (Rattus norvegicus) | 6480464 | glycidol results in decreased expression of PROCA1 mRNA | CTD | PMID:24915197 | glycidyl methacrylate | increases expression | EXP | | 6480464 | glycidyl methacrylate results in increased expression of PROCA1 protein | CTD | PMID:36641056 | methapyrilene | decreases methylation | EXP | | 6480464 | Methapyrilene results in decreased methylation of PROCA1 intron | CTD | PMID:30157460 | methimazole | decreases expression | ISO | Proca1 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of PROCA1 mRNA | CTD | PMID:30047161 | ozone | multiple interactions | ISO | Proca1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PROCA1 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of PROCA1 mRNA | CTD | PMID:34911549 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of PROCA1 mRNA | CTD | PMID:22230336 | paracetamol | decreases expression | ISO | Proca1 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of PROCA1 mRNA | CTD | PMID:33387578 | PCB138 | multiple interactions | ISO | Proca1 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | pirinixic acid | increases expression | ISO | Proca1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of PROCA1 mRNA | CTD | PMID:23811191 | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of PROCA1 mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PROCA1 mRNA | CTD | PMID:27188386 | thioacetamide | increases expression | ISO | Proca1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of PROCA1 mRNA | CTD | PMID:23411599 and PMID:34492290 | toluene | decreases expression | EXP | | 6480464 | Toluene results in decreased expression of PROCA1 mRNA | CTD | PMID:28245982 | trichloroethene | decreases expression | ISO | Proca1 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of PROCA1 mRNA | CTD | PMID:33387578 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of PROCA1 mRNA | CTD | PMID:24935251 | triptonide | increases expression | ISO | Proca1 (Mus musculus) | 6480464 | triptonide results in increased expression of PROCA1 mRNA | CTD | PMID:33045310 | troglitazone | increases expression | ISO | Proca1 (Mus musculus) | 6480464 | troglitazone results in increased expression of PROCA1 mRNA | CTD | PMID:28973697 | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of PROCA1 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of PROCA1 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of PROCA1 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PROCA1 mRNA | CTD | PMID:27188386 | |